Association of Heparin-Like Effect, Factor VII/XIII Deficiency and Fibrinolysis with Rebleeding Risk in Cirrhosis with Acute Variceal Bleeding-Reference-Cited by-同舟云学术

Association of Heparin-Like Effect, Factor VII/XIII Deficiency and Fibrinolysis with Rebleeding Risk in Cirrhosis with Acute Variceal Bleeding

Published:2022-08-19 Issue:2 Volume:68 Page:497-513
ISSN:0163-2116
Container-title:Digestive Diseases and Sciences
language:en
Short-container-title:Dig Dis Sci

Author:

Premkumar Madhumita^ORCID,Mehtani Rohit,Kulkarni Anand V.,Duseja Ajay Kumar,De Arka,Taneja Sunil,Singh Virendra,Verma Nipun,Ahluwalia Jasmina,Kajal Kamal,Divyaveer Smita,Roy Akash,Gandotra Akash,Kalson Narender,Kekan Kushal,Kaur Harmanpreet,Kaur Harpreet

Funder

PGIMER Intramural Grant

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,Physiology

Link

https://link.springer.com/content/pdf/10.1007/s10620-022-07656-9.pdf

Reference34 articles.

1. Premkumar M, Bihari C, Saxena P et al. Heparin-like Effect Associated With Risk of Bleeding, Sepsis, and Death in Patients With Severe Alcohol-Associated Hepatitis. Clin Gastroenterol Hepatol. 2020;18:486-495.e3.

2. Premkumar M, Sarin SK. Current Concepts in Coagulation Profile in Cirrhosis and Acute-on-Chronic Liver Failure. Clin Liver Dis (Hoboken). 2020;16:158–167.

3. Thalheimer U, Triantos C, Samonakis D et al. Endogenous heparinoids in acute variceal bleeding. Gut. 2005;54:310–311.

4. Premkumar M, Saxena P, Rangegowda D et al. Coagulation failure is associated with bleeding events and clinical outcome during systemic inflammatory response and sepsis in acute-on-chronic liver failure: An observational cohort study. Liver Int. 2019;39:694–704.

5. Bernard B, Cadranel JF, Valla D et al. Prognostic significance of bacterial infection in bleeding cirrhotic patients: a prospective study. Gastroenterology. 1995;108:1828–1834.

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Review article: Evaluation and care of the critically ill patient with cirrhosis;Alimentary Pharmacology & Therapeutics;2024-05